Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Edonerpic - FUJIFILM Toyama Chemical

Next Previous
Drug Profile

Edonerpic - FUJIFILM Toyama Chemical

Alternative Names: Edonerpic maleate - FUJIFILM Toyama Chemical; T-817 MA

Latest Information Update: 31 Oct 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Toyama Chemical
  • Developer FUJIFILM Toyama Chemical; Toyama Chemical
  • Class Antidementias; Neuroprotectants; Small molecules; Vascular disorder therapies
  • Mechanism of Action Amyloid beta-protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Alzheimer's disease; Stroke

Most Recent Events

  • 26 Apr 2022 Edonerpic is still in phase-II trials for Stroke in Japan (JapicCTI-194711) (FUJIFILM Toyama Chemical pipeline, April 2022)
  • 26 Apr 2022 Edonerpic is still in phase-II trials for Alzheimer's disease in Netherlands, Germany, Spain and Hungary (PO) (EudraCT2018-003567-66) (FUJIFILM Toyama Chemical pipeline, April 2022)
  • 06 Aug 2019 Phase-II clinical trials in Stroke in Japan (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top